![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Spectranetics Earns CE Mark for AngioSculptX Drug-coated Catheter
Spectranetics Earns CE Mark for AngioSculptX Drug-coated Catheter
Spectranetics has attained CE Mark approval in the EU for its AngioSculptX drug-coated balloon catheter designed to treat coronary artery stenosis.
The device also was granted indications for the treatment of hemodynamically significant coronary artery stenosis, including in-stent restinosis, the company said.
It is meant to be used in percutaneous transluminal coronary angioplasty procedures. — Cynthia Jessup
Upcoming Events
-
11Jul
-
18Jul
-
21Oct